HCPLive Network

MR-US Fusion Targeted Biopsy Ups Detection of Prostate Cancer

 
THURSDAY, Dec. 13 (HealthDay News) -- Targeted biopsy of suspected prostate cancer lesions, identified using magnetic resonance-ultrasound (MR-US) fusion, increases prostate cancer detection and detects aggressive tumors that may be missed by conventional biopsy, according to a study published in the January issue of The Journal of Urology.

Geoffrey A. Sonn, M.D., from the University of California Los Angeles, and colleagues used MR-US fusion prostate biopsy in 171 men (median age, 65 years) undergoing biopsy as part of active surveillance (106 men) or due to increased prostate-specific antigen levels with a prior negative conventional biopsy (65 men). MR-US fusion prostate biopsy locates lesions by magnetic resonance imaging (MRI) and fuses it with real-time ultrasound to generate a three-dimensional prostate model to allow targeted sampling. The men also had conventional systematic biopsies taken.

The researchers identified prostate cancer in 53 percent of men, of whom 38 percent had cancer with Gleason grade 7 or greater. Of these highly-aggressive cancers, 38 percent were detected only by targeted biopsy. Of the 16 men with the highest level of suspicion by MRI (image grade 5 target), 94 percent had prostate cancer.

"Prostate lesions identified on MRI can be accurately targeted with MR-US fusion biopsy in a clinic setting using local anesthesia," Sonn and colleagues conclude. "Targeted prostate biopsy has the potential to improve the diagnosis of prostate cancer and may aid in the selection of patients for active surveillance and focal therapy."
 

Abstract
Full Text (subscription or payment may be required)

 
Copyright © 2012 HealthDay. All rights reserved.
 
 
Further Reading
Inclusion of endogenous hormones in prediction models improves prediction of invasive breast cancer risk in postmenopausal women, according to a study published online Aug. 18 in the Journal of Clinical Oncology.
Reduced nicotine cigarettes are not associated with increased smoking intensity versus usual brand cigarettes, according to a study published online Aug. 22 in Cancer Epidemiology, Biomarkers & Prevention.
Sunscreen use has decreased among adolescents, and a considerable proportion use indoor tanning devices, according to research published online Aug. 21 in the US Centers for Disease Control and Prevention's Preventing Chronic Disease.
High-mitotic-rate primary cutaneous melanomas more often occur on the head and neck and in men, older patients, and those with a history of solar keratosis, according to a study published online Aug. 20 in JAMA Dermatology.
Vagal innervation is involved in gastric tumorigenesis, according to an experimental study published in the Aug. 20 issue of Science Translational Medicine.
Cerdelga (eliglustat) has been approved by the US Food and Drug Administration to treat type 1 Gaucher disease, a rare inherited disorder caused by the body's insufficient production of a key enzyme.
More than 40% of women undergo breast reconstruction following mastectomy and most patients are satisfied with the reconstruction decision-making process, according to a study published online Aug. 20 in JAMA Surgery.
More Reading